News
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...
US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need - FDA approval paves the way for the ...
FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant ...
The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...
Hosted on MSN18h
Wistar is investing $24 million to find a cure for HIVPenn’s Carl June splits a $3 million Breakthrough Prize for pioneering the cancer treatment CAR-T With HIV, the key to a ...
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high ...
Gilead has been a leader in HIV innovation for decades. Now, we're proud to share that one of our researchers, Moupali Das, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback